* Nephros Inc NEPH.OQ reported a quarterly adjusted loss
of 6
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -10
cents. The mean expectation of two analysts for the quarter was
for a loss of 2 cents per share. Wall Street expected results to
range from -4 cents to -1 cents per share.
* Revenue rose 27.2% to $3.25 million from a year ago;
analysts
expected $3.81 million.
* Nephros Inc's reported EPS for the quarter was a loss of 6
cents.
* The company reported a quarterly loss of $654 thousand.
* Nephros Inc shares had fallen by 10.4% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the environmental
services & equipment peer group is "hold."
Wall Street's median 12-month price target for Nephros Inc is
$4.50
This summary was machine generated from LSEG data March 8 at
04:25 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.02 -0.06 Missed
Sep. 30 2023 -0.06 -0.02 Beat
Jun. 30 2023 -0.05 -0.04 Beat
Mar. 31 2023 -0.02 -0.03 Missed